Jingxian Ding Yali Cao Yonghong Guo
10.3389/fonc.2022.832763
Front Oncol
2022 Apr 13;12:832763.
17β-estradiol (e2) antihormonal therapy breast cancer fulvestrant reirradiation (re-rt)
CC BY
https://pubmed.ncbi.nlm.nih.gov/35494071/
Case Reports
PMC9045700
35494071
Fulvestrant May Falsely Increase 17β-Estradiol Levels in Immunoassays: A Case Report of a 57-Year-Old Postmenopausal Patient With Recurrent Estrogen Receptor-Positive Breast Cancer
2022